SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001311230-16-000019
Filing Date
2016-04-25
Accepted
2016-04-25 17:08:08
Documents
6
Period of Report
2016-06-08
Effectiveness Date
2016-04-25

Document Format Files

Seq Description Document Type Size
1 DEF 14A proxysolazyme2016-06x08.htm DEF 14A 829448
2 sigsolazymea04.jpg GRAPHIC 4282
3 solazymea08.jpg GRAPHIC 6196
4 solazymea09.jpg GRAPHIC 6196
5 solazymeproxycarda03.jpg GRAPHIC 211985
6 solazymeproxycardcv02.jpg GRAPHIC 244492
  Complete submission text file 0001311230-16-000019.txt   1482305
Mailing Address 225 GATEWAY BLVD. S. SAN FRANCISCO CA 94080
Business Address 225 GATEWAY BLVD. S. SAN FRANCISCO CA 94080 650-780-4777
SOLAZYME INC (Filer) CIK: 0001311230 (see all company filings)

IRS No.: 331077078 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35189 | Film No.: 161589647
SIC: 2860 Industrial Organic Chemicals